Dr. Lal Path Labs · NSE: LALPATHLAB · BSE: 539524
Q3 FY20 results · Oct–Dec 2019
Dr. Lal Path Labs reported revenue from operations of ₹327.90 crore (up 12.1% from Q3 FY19) and net profit of ₹54.90 crore (up 19.1% from Q3 FY19) for Q3 FY20 (Oct–Dec 2019), on a consolidated basis.
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 327.90 | 292.50 | +12.1% | 365.60 | −10.3% |
| Other income | 13.80 | 12.20 | +13.1% | 14.80 | −6.8% |
| Total income | 341.70 | 304.70 | +12.1% | 380.40 | −10.2% |
| Profit before tax | 73.40 | 67.90 | +8.1% | 102.30 | −28.3% |
| Net profit for the period | 54.90 | 46.10 | +19.1% | 81.00 | −32.2% |
| Attributable to shareholders of the company | 54.10 | 45.80 | +18.1% | 80.50 | −32.8% |
| EPS, basic (₹) | 6.56 | 5.56 | +18.0% | 9.77 | −32.9% |
| Net margin (%) | 16.7 | 15.8 | 22.2 |
| Item | Q3 FY20 | Q3 FY19 | YoY | Q2 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 310.40 | 282.80 | +9.8% | 351.20 | −11.6% |
| Other income | 13.30 | 11.90 | +11.8% | 16.20 | −17.9% |
| Total income | 323.70 | 294.70 | +9.8% | 367.40 | −11.9% |
| Profit before tax | 68.60 | 65.30 | +5.1% | 99.80 | −31.3% |
| Net profit for the period | 51.10 | 44.30 | +15.3% | 79.50 | −35.7% |
| EPS, basic (₹) | 6.20 | 5.38 | +15.2% | 9.65 | −35.8% |
| Net margin (%) | 16.5 | 15.7 | 22.6 |
Consolidated
- Filed with BSE
- 03 Feb 2020, 18:21 IST
- Board meeting
- 03 Feb 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 03 Feb 2020, 18:21 IST
- Board meeting
- 03 Feb 2020
- Period
- 01 Oct 2019 to 31 Dec 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE